Developing efficient search strategies to identify reports of adverse effects in medline and embase
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: This study aimed to assess the performance, in terms of sensitivity and precision, of different approaches to searching medline and embase to identify studies of adverse effects. Methods: Five approaches to searching for adverse effects evidence were identified: approach 1, using specified adverse effects; approach 2, using subheadings/qualifiers; approach 3, using text words; approach 4, using indexing terms; approach 5, searching for specific study designs. The sensitivity and precision of these five approaches, and combinations of these approaches, were compared in a case study using a systematic review of the adverse effects of seven anti‐epileptic drugs. Results: The most sensitive search strategy in medline (97.0%) required a combination of terms for specified adverse effects, floating subheadings, and text words for ‘adverse effects’. In embase, a combination of terms for specified adverse effects and text words for ‘adverse effects’ provided the most sensitive search strategy (98.6%). Both these search strategies yielded low precision (2.8%). Conclusions: A highly sensitive search in either database requires a combination of approaches, and has low precision. This suggests that better reporting and indexing of adverse effects is required and that an effective generic search filter may not yet be feasible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.
Papanikolaou, P. N., & Ioannidis, J. P. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.04.026 · Cited by 79
Research works printed but not linked: 37
- Li wan Po A. Herxheimer A. Poolsup N.&Aziz Z.How do Cochrane reviewers address adverse effects of drug therapy?In:8th Annual Conference Colloquium Abstracts October 2000 Cape Town.2000. Available from:http://www.cochrane.org/colloquia/abstracts/capetown/capetowno39.html(accessed 21 September 2005).
- 10.5694/j.1326-5377.2004.tb06241.x · DOI
- 10.2165/00002018-200427110-00001 · DOI
- 10.1136/bmj.323.7312.546 · DOI · Paper page
- 10.1001/archinte.161.8.1041 · DOI
- 10.1016/S0895-4356(02)00393-1 · DOI
- 10.1111/j.0306-5251.2003.02055.x · DOI · Paper page
- 10.1136/bmj.327.7406.65 · DOI · Paper page
- Zhang W. Y.Evidence from case‐control and cohort studies for adverse drug reaction—a case study of analgesic nephropathy. In:9th Annual Cochrane Colloquium Abstracts October 2001 Lyon.2001. Available from:http://www.biomedcentral.com/abstracts/COCHRANE/1/pc149/(accessed 21 September 2005). · doi:10.1186/2048-4623-1-s3-pc149
- 10.1046/j.1472-8206.2002.00066.x · DOI · Paper page
- 10.1136/bmj.284.6311.249 · DOI
- 10.1136/bmj.329.7456.2 · DOI
- 10.1186/1471-2288-1-7 · DOI · Paper page
- 10.1016/j.jclinepi.2004.11.018 · DOI
- 10.7326/0003-4819-114-4-298 · doi:10.7326/0003-4819-114-4-298
- 10.3310/hta7130 · DOI · Paper page
- Adab N., The Cochrane Database of Systematic Reviews
- Thomson Dialog., 2005, Searching for Adverse Effects of a Drug: A Remote Learning Briefing.
- Thomson Dialog., 2005, Search Solutions Biomed: Searching for Adverse Effects of a Drug in embase® and medline®
- Buckingham J., 2005, Ovid medline/pubmed Search strategies for articles on causation/ harm/etiology
- 10.1186/1472-6904-2-6 · DOI
- Herxheimer A., The Cochrane Database of Systematic Reviews
- Centre for Reviews and Dissemination., 2005, Searching for Information on Adverse Effects
- 10.3310/hta6160 · DOI · Paper page
- Shekelle P. G., 2003, Ephedra and Ephedrine for Weight Loss and Athletic Performance Enhancement: Clinical Efficacy and Side Effects
- National Library of Medicine, 2005, Fact Sheet: toxline
- 10.3310/hta9150 · DOI · Paper page
- Biarez O., 1991, Comparison and evaluation of nine bibliographic databases concerning adverse drug reactions, DICP: The Annals of Pharmacotherapy, 25, 1062, 10.1177/106002809102501005 · DOI · Paper page
- Dukes M. N. G., 2000, Meyler's Side‐Effects of Drugs: an Encyclopedia of Adverse Reactions and Interactions
- Sweetman S. C., 2002, Martindale: The Complete Drug Reference
- ABPI Medicines., 2002, Compendium.
- American Society of Health‐System Pharmacists., 2002, AHFSfirst Professional Edition
- British Medical Association/Royal Pharmaceutical Society of Great Britain., 2002, British National Formulary (BNF).
- National Library of Medicine, 2005, MeSH Browser (2005 MeSH)
- Elsevier Science, 2005, EMTREE 2005: The Life Science Thesaurus
- Schulman J.‐L., 2003, What's new for 2004 MeSH, NLM Technical Bulletin, 335, e3
- 10.1177/016555150102700601 · DOI · Paper page
Cited by
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
“, questions relating to benefits and questions relating to harms), we recommend authors provide at least one example of a strategy for each part of the objective [69].”
BackgroundLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Italian Journal of Public Health · doi:10.2427/5768 · Cited by 3,374
Metadata
- Authors
- Golder, S., McIntosh, H. M., Duffy, S., & Glanville, J.
- Venue
- Health Information & Libraries Journal
- Publisher
- Wiley
- Published
- 2006-02-08
- Volume
- 23
- Issue
- 1
- Pages
- 3-12
- ISSN
- 1471-1834 (ISSN-L)
- 1471-1842
- OpenAlex
- W2076859891
- Cited by
- 117
- References
- 5
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.